MBX Biosciences (MBX) stock is currently trading at $9.25, reflecting a sharp pre-market drop of 23.2% due to negative sentiment and potential concerns over its fundamentals. Bulls may argue that the stock is oversold, presenting a potential rebound opportunity if it stabilizes near this level. However, without clear catalysts or improved sentiment, the stock may face continued pressure.